Related Experiment Video

Updated: Nov 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K

A cost-effectiveness analysis of the Chronic Disease Management Program in patients with hypertension in Korea

Woorim Kim1, Sang Ah Lee2, Sung-Youn Chun2

  • 1Division of Cancer Control and Policy, National Cancer Control Institute, National Cancer Center, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 10408, Republic of Korea.

International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|April 15, 2021
PubMed

Insights

Korea's Chronic Disease Management Program (CDMP) is highly cost-effective for managing hypertension in adults aged 40 and above. This program improves care continuity and reduces healthcare costs.

Area of Science:

  • Health Economics
  • Public Health Policy
  • Chronic Disease Management

Background:

  • Korea's Chronic Disease Management Program (CDMP) aims to enhance care continuity for patients with hypertension and diabetes.
  • Hypertension management is a significant public health concern requiring effective and efficient interventions.

Purpose of the Study:

  • To evaluate the cost-effectiveness of the CDMP for hypertension patients from a healthcare payer's perspective.
  • To determine the economic value of improved care coordination in managing chronic conditions.

Main Methods:

  • A Markov simulation model was employed for cost-effectiveness analysis.
  • Compared the CDMP against usual care for individuals aged 40+ over their lifetime.
  • Calculated the Incremental Cost-Effectiveness Ratio (ICER) using Quality-Adjusted Life Years (QALYs).

Main Results:

  • The CDMP demonstrated a negative ICER (-5,761,088 KRW/QALY), indicating cost-effectiveness compared to usual care.
  • Cost-effectiveness was consistent across different population subsets, including clinic users and national health examination participants.

Conclusions:

  • The CDMP is a highly cost-effective strategy for managing hypertension in adults aged 40 and above.
  • Policy implementation should focus on enhancing care coordination to improve patient outcomes and healthcare efficiency.
Abstract

Keywords:
economic evaluationhealth policyhypertensionpatient outcomesprimary care

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

606
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
127
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
128
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.1K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
239
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
175
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
98